The number needed to treat (NNT) as a measure of drug efficacy: the case of zoledronic acid for early hormone-responsive breast cancer in the ABCSG-12 trial

M Gnant; Brigitte Mlineritsch; W Schippinger; G Luschin-Ebengreuth; G Steger; V Bjelic-Radisic; R Jakesz; E Kubista; C Marth; Richard Greil

The number needed to treat (NNT) as a measure of drug efficacy: the case of zoledronic acid for early hormone-responsive breast cancer in the ABCSG-12 trial

M Gnant
, Brigitte Mlineritsch
, W Schippinger
, G Luschin-Ebengreuth
, G Steger
, V Bjelic-Radisic
, R Jakesz
, E Kubista
, C Marth
, Richard Greil

Universitätsklinik für Innere Medizin 3 - Hämatologie, internistische Onkologie, Hämostaseologie, Infektiologie, Rheumatologie und Onkologisches Zentrum

Publikation: Beitrag in Fachzeitschrift › Abstrakt (Zeitschrift) › Begutachtung

Originalsprache	Englisch
Seiten (von - bis)	191S-191S
Fachzeitschrift	CANCER RESEARCH
Jahrgang	69
Ausgabenummer	2
Publikationsstatus	Veröffentlicht - 2009
Veranstaltung	31st Annual San Antonio Breast Cancer Symposium - San Antonio, TX Dauer: 10 Jan. 2008 → 14 Jan. 2008

Dieses zitieren

Gnant, M., Mlineritsch, B., Schippinger, W., Luschin-Ebengreuth, G., Steger, G., Bjelic-Radisic, V., Jakesz, R., Kubista, E., Marth, C., & Greil, R. (2009). The number needed to treat (NNT) as a measure of drug efficacy: the case of zoledronic acid for early hormone-responsive breast cancer in the ABCSG-12 trial. CANCER RESEARCH , 69(2), 191S-191S.

Gnant, M ; Mlineritsch, Brigitte ; Schippinger, W et al. / The number needed to treat (NNT) as a measure of drug efficacy: the case of zoledronic acid for early hormone-responsive breast cancer in the ABCSG-12 trial. in: CANCER RESEARCH 2009 ; Jahrgang 69, Nr. 2. S. 191S-191S.

@article{f50ccce49f4645059dc9525ea016282a,

title = "The number needed to treat (NNT) as a measure of drug efficacy: the case of zoledronic acid for early hormone-responsive breast cancer in the ABCSG-12 trial",

author = "M Gnant and Brigitte Mlineritsch and W Schippinger and G Luschin-Ebengreuth and G Steger and V Bjelic-Radisic and R Jakesz and E Kubista and C Marth and Richard Greil",

year = "2009",

language = "English",

volume = "69",

pages = "191S--191S",

journal = "CANCER RESEARCH ",

issn = "0008-5472",

publisher = "Amer Assoc Cancer Research",

number = "2",

note = "31st Annual San Antonio Breast Cancer Symposium ; Conference date: 10-01-2008 Through 14-01-2008",

}

Gnant, M, Mlineritsch, B, Schippinger, W, Luschin-Ebengreuth, G, Steger, G, Bjelic-Radisic, V, Jakesz, R, Kubista, E, Marth, C & Greil, R 2009, 'The number needed to treat (NNT) as a measure of drug efficacy: the case of zoledronic acid for early hormone-responsive breast cancer in the ABCSG-12 trial', CANCER RESEARCH , Jg. 69, Nr. 2, S. 191S-191S.

The number needed to treat (NNT) as a measure of drug efficacy: the case of zoledronic acid for early hormone-responsive breast cancer in the ABCSG-12 trial. / Gnant, M; Mlineritsch, Brigitte; Schippinger, W et al.
in: CANCER RESEARCH , Jahrgang 69, Nr. 2, 2009, S. 191S-191S.

Publikation: Beitrag in Fachzeitschrift › Abstrakt (Zeitschrift) › Begutachtung

TY - JOUR

T1 - The number needed to treat (NNT) as a measure of drug efficacy: the case of zoledronic acid for early hormone-responsive breast cancer in the ABCSG-12 trial

AU - Gnant, M

AU - Mlineritsch, Brigitte

AU - Schippinger, W

AU - Luschin-Ebengreuth, G

AU - Steger, G

AU - Bjelic-Radisic, V

AU - Jakesz, R

AU - Kubista, E

AU - Marth, C

AU - Greil, Richard

PY - 2009

Y1 - 2009

M3 - Abstract (Journal)

SN - 0008-5472

VL - 69

SP - 191S-191S

JO - CANCER RESEARCH

JF - CANCER RESEARCH

IS - 2

T2 - 31st Annual San Antonio Breast Cancer Symposium

Y2 - 10 January 2008 through 14 January 2008

ER -

Gnant M, Mlineritsch B, Schippinger W, Luschin-Ebengreuth G, Steger G, Bjelic-Radisic V et al. The number needed to treat (NNT) as a measure of drug efficacy: the case of zoledronic acid for early hormone-responsive breast cancer in the ABCSG-12 trial. CANCER RESEARCH . 2009;69(2):191S-191S.